Dexrazoxane ameliorates radiation-induced heart disease in a rat model

Treatment of thoracic tumors with radiotherapy can lead to severe cardiac injury. We investigated the effects of dexrazoxane, a USFDA-approved cardioprotective drug administered with chemotherapy, on radiation-induced heart disease (RIHD) in a rat model. Male Sprague-Dawley rats were irradiated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Long, Nie, Xiaoqi, Zhang, Peng, Huang, Yongbiao, Ma, Li, Li, Fang, Yi, Minxiao, Qin, Wan, Yuan, Xianglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906151/
https://www.ncbi.nlm.nih.gov/pubmed/33406500
http://dx.doi.org/10.18632/aging.202332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906151/
https://www.ncbi.nlm.nih.gov/pubmed/33406500
http://dx.doi.org/10.18632/aging.202332

Ejemplares similares